pentetic acid has been researched along with Carcinoma, Small Cell in 24 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Excerpt | Relevance | Reference |
---|---|---|
" Pharmacokinetics obtained from plasma radioactivity showed plasma disappearance described most properly by a monoexponential model with a mean half-life value of 17." | 1.29 | Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma. ( de Jonge, MW; de Leij, L; Groen, HJ; Kengen, RA; Kosterink, JG; Piers, DA; Postmus, PE; Shochat, D; Smit, EF; The, HT, 1995) |
"In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.17) | 18.7374 |
1990's | 20 (83.33) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, P | 2 |
Ahlman, H | 2 |
Nilsson, O | 2 |
Benjegård, SA | 1 |
Forssell-Aronsson, E | 2 |
Schmitt, A | 1 |
Kölby, L | 1 |
Vogl, TJ | 1 |
Friebe, CE | 1 |
Balzer, T | 1 |
Mack, MG | 1 |
Steiner, S | 1 |
Schedel, H | 1 |
Pegios, W | 1 |
Lanksch, W | 1 |
Banzer, D | 1 |
Felix, R | 1 |
Koshimoto, Y | 1 |
Maeda, M | 1 |
Naiki, H | 1 |
Nakakuki, K | 1 |
Ishii, Y | 1 |
Bombardieri, E | 4 |
Crippa, F | 3 |
Cataldo, I | 2 |
Chiti, A | 3 |
Seregni, E | 2 |
Soresi, E | 4 |
Boffi, R | 3 |
Invernizzi, G | 2 |
Buraggi, GL | 2 |
Kwekkeboom, DJ | 3 |
Kho, GS | 1 |
Lamberts, SW | 2 |
Reubi, JC | 1 |
Laissue, JA | 1 |
Krenning, EP | 3 |
Nomoto, Y | 1 |
Miyamoto, T | 1 |
Yamaguchi, Y | 1 |
Kosterink, JG | 1 |
de Jonge, MW | 1 |
Smit, EF | 1 |
Piers, DA | 1 |
Kengen, RA | 1 |
Postmus, PE | 1 |
Shochat, D | 1 |
Groen, HJ | 1 |
The, HT | 1 |
de Leij, L | 1 |
Habbema, JD | 1 |
Berenger, N | 1 |
Moretti, JL | 1 |
Boaziz, C | 1 |
Vigneron, N | 1 |
Morere, JF | 1 |
Breau, JL | 1 |
D'addabbo, A | 1 |
Simeone, G | 1 |
Rubini, G | 1 |
Nitti, L | 1 |
Maffioli, L | 1 |
Semprebene, A | 1 |
Ferraironi, A | 1 |
Franciotti, G | 1 |
Venturo, I | 1 |
Giunta, S | 1 |
Lopez, M | 1 |
Maini, CL | 1 |
Possa, M | 1 |
Ciavarella, GP | 1 |
Liuzzi, A | 1 |
Hochstenbag, MM | 1 |
Heidendal, GA | 1 |
Wouters, EF | 1 |
ten Velde, GP | 1 |
Reisinger, I | 1 |
Bohuslavitzki, KH | 1 |
Brenner, W | 1 |
Braune, S | 1 |
Dittrich, I | 1 |
Geide, A | 1 |
Kettner, B | 1 |
Otto, HJ | 1 |
Schmidt, S | 1 |
Munz, DL | 1 |
García Vicente, A | 1 |
Soriano Castrejón, A | 1 |
Alonso Farto, J | 1 |
Soler, E | 1 |
García del Castillo, E | 1 |
Vuillez, JP | 1 |
Kraeber-Bodéré, F | 1 |
Moro, D | 1 |
Bardiès, M | 1 |
Douillard, JY | 1 |
Gautherot, E | 1 |
Rouvier, E | 1 |
Barbet, J | 1 |
Garban, F | 1 |
Moreau, P | 1 |
Chatal, JF | 1 |
Kusumoto, M | 1 |
Maruta, T | 1 |
Narabayashi, I | 1 |
Suematsu, T | 1 |
Hirata, Y | 1 |
Ueda, E | 1 |
Ogawa, K | 1 |
Mieda, C | 1 |
Okada, K | 1 |
Ikeda, Y | 1 |
Hirota, S | 1 |
Nelson, DR | 1 |
Dolan, KD | 1 |
Nägele, M | 1 |
Hahn, D | 1 |
Seelos, K | 1 |
Lissner, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors[NCT04790708] | 250 participants (Anticipated) | Interventional | 2018-07-02 | Recruiting | |||
Phase I/II Study of Lutathera in Pediatric and Young Adult Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Express Somatostatin Type2A Receptors and Demonstrate Uptake on DOTATATE PET[NCT05278208] | Phase 1/Phase 2 | 65 participants (Anticipated) | Interventional | 2022-11-21 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for pentetic acid and Carcinoma, Small Cell
Article | Year |
---|---|
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
Somatostatin receptor imaging.
Topics: Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplas | 2002 |
4 trials available for pentetic acid and Carcinoma, Small Cell
Article | Year |
---|---|
[Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Non-Smal | 1995 |
Brain metastasis of small cell lung carcinoma: comparison of Gd-DTPA enhanced magnetic resonance imaging and enhanced computerized tomography.
Topics: Brain Neoplasms; Carcinoma, Small Cell; Gadolinium DTPA; Humans; Image Enhancement; Lung Neoplasms; | 1994 |
Somatostatin receptor imaging in small cell lung cancer.
Topics: Adult; Aged; Bone Neoplasms; Carcinoma, Small Cell; Female; Humans; Indium Radioisotopes; Lung Neopl | 1996 |
Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: results of a phase I/II trial.
Topics: Aged; Animals; Antibodies, Anti-Idiotypic; Antibodies, Bispecific; Carcinoembryonic Antigen; Carcino | 1999 |
19 other studies available for pentetic acid and Carcinoma, Small Cell
Article | Year |
---|---|
Evaluation of (111)In labeled somatostatin analogs for targeted therapy of somatostatin receptor positive tumors.
Topics: Carcinoma, Small Cell; Cell Survival; Humans; Indium Radioisotopes; Lung Neoplasms; Octreotide; Pent | 2003 |
Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
Topics: Animals; Carcinoma, Small Cell; Cell Line, Tumor; Disease Models, Animal; Humans; Indium Radioisotop | 2005 |
MR of pituitary metastasis in a patient with diabetes insipidus.
Topics: Aged; Carcinoma, Small Cell; Contrast Media; Diabetes Insipidus; Drug Combinations; Fatal Outcome; G | 1995 |
Somatostatin receptor imaging of small cell lung cancer (SCLC) by means of 111In-DTPA octreotide scintigraphy.
Topics: Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Indium Radioisotopes; | 1995 |
111In-octreotide uptake in granulomatous and tumor lesions in a patient with small-cell lung cancer.
Topics: Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung; Lung Neoplasms; Lymphomatoid Granulomatos | 1994 |
The value of octreotide scintigraphy in patients with lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Diagnosis, Differential; Female; Humans | 1994 |
Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.
Topics: Antibodies, Monoclonal; Carcinoma, Small Cell; Humans; Indium Radioisotopes; Lung Neoplasms; Penteti | 1995 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
Description of a multicompartmental model of the biodistribution of 111In-DTPA-D-Phe-1-octreotide in human.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Computer Simulation; Female; Humans; Indium Radioisotopes; Ki | 1995 |
111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Hormonal; Bone Neoplasms; Carcinoma, Small Cell; Diagno | 1995 |
111In-octreotide scintigraphy in small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Injections, In | 1995 |
Intensification of 111In-DTPA-octreotide scintigraphy by means of pretreatment with cold octreotide in small cell lung cancer.
Topics: Adrenal Gland Neoplasms; Aged; Bone Neoplasms; Brain Neoplasms; Carcinoma, Small Cell; Humans; Indiu | 1997 |
In-111 octreotide imaging in staging of small cell lung cancer.
Topics: Carcinoma, Small Cell; Female; Humans; Indium Radioisotopes; Lung Neoplasms; Male; Middle Aged; Neop | 1997 |
Somatostatin receptor scintigraphy in small-cell lung cancer: results of a multicenter study.
Topics: Adult; Aged; Carcinoma, Small Cell; Female; Humans; Lung; Lung Neoplasms; Male; Middle Aged; Octreot | 1998 |
[Merkel cell carcinoma. Utility of scintigraphy with 111In-DTPA-pentetreotide].
Topics: Aged; Biomarkers, Tumor; Carcinoma, Merkel Cell; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Di | 1999 |
[Clinical studies for usefulness of Gd-DTPA enhanced MRI in lung cancer].
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Contrast Media; Gadolinium; Gadolin | 1992 |
[Clinical value of Gd-DTPA enhanced MRI of pulmonary and mediastinal tumors].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Fem | 1991 |
Cerebellopontine angle metastatic lung carcinoma resembling an acoustic neuroma.
Topics: Aged; Carcinoma, Small Cell; Cerebellar Neoplasms; Cerebellopontine Angle; Gadolinium; Gadolinium DT | 1991 |
[Gd-DTPA contrast enhancement in the nuclear magnetic resonance tomographic diagnosis of thoracic space-occupying lesions].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carc | 1988 |